(Q33436043)

26 July 2017

Oncologist use of the Adjuvant! model for risk communication: a pilot study examining patient knowledge of 10-year prognosis (English)

1 reference

26 July 2017

1 reference

1 reference

6

Laura J Esserman

1 reference

26 July 2017

2

Hope S Rugo

1 reference

26 July 2017

Jeffrey K Belkora

1

1 reference

26 July 2017

Dan H Moore

series ordinal

3

1 reference

26 July 2017

David W Hutton

series ordinal

4

1 reference

26 July 2017

Daniel F Chen

series ordinal

5

1 reference

26 July 2017

language of work or name

English

0 references

publication date

28 April 2009

1 reference

26 July 2017

1 reference

26 July 2017

9

1 reference

26 July 2017

127

1 reference

Creative Commons Attribution 2.0 Generic

26 July 2017

start time

28 April 2009

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

exact match

https://scigraph.springernature.com/pub.10.1186/1471-2407-9-127

0 references

cites work

Assessing risk communication in breast cancer: are continuous measures of patient knowledge better than categorical?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684746

Improving understanding of adjuvant therapy options by using simpler risk graphics

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684746

Numeric, verbal, and visual formats of conveying health risks: suggested best practices and future recommendations

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684746

Cognitive function in breast cancer patients prior to adjuvant treatment

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684746

A decision aid to assist in adjuvant therapy choices for breast cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684746

Decreased use of adjuvant breast cancer therapy in a randomized controlled trial of a decision aid with individualized risk information

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684746

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684746

Population-based validation of the prognostic model ADJUVANT! for early breast cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684746

The impact of adjuvant therapy for breast cancer on cognitive function: current evidence and directions for research

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684746

Strategies to help patients understand risks

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684746

Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684746

What does it mean to understand a risk? Evaluating risk comprehension

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684746

Monitoring versus blunting styles of coping with cancer influence the information patients want and need about their disease. Implications for cancer screening and management

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684746

Acute myeloid leukemia and myelodysplastic syndrome after doxorubicin-cyclophosphamide adjuvant therapy for operable breast cancer: the National Surgical Adjuvant Breast and Bowel Project Experience

21 June 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1471-2407-9-127

Risk communication with patients with breast cancer: cautionary notes about printing Adjuvant! estimates.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1471-2407-9-127

Monitoring and blunting: validation of a questionnaire to assess styles of information seeking under threat

21 January 2018

1 reference

12 December 2020

A computer program to assist in making breast cancer adjuvant therapy decisions

1 reference

12 December 2020

A computer based program to assist in adjuvant therapy decisions for individual breast cancer patients

1 reference

12 December 2020

Are patients getting the "gist" in risk communication? Patient understanding of prognosis in breast cancer treatment

1 reference

12 December 2020

Helping Patients Make Informed Choices: A Randomized Trial of a Decision Aid for Adjuvant Chemotherapy in Lymph Node-Negative Breast Cancer

1 reference

12 December 2020

Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2407-9-127

1 reference

Dimensions Publication ID

26 July 2017

0 references

1 reference

26 July 2017

1 reference